NCT06624644 2025-09-10A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory MelanomaLinnaeus Therapeutics, Inc.Phase 2/3 Recruiting135 enrolled
NCT03970447 2025-09-09GBM AGILEGlobal Coalition for Adaptive ResearchPhase 2/3 Recruiting1,280 enrolled